Loading…
Curcuminoid compounds from turmeric root that inhibit NF-κB and COX-2 inflammatory pathways; poorly absorbed alone, so formulations often add piperine or fats to improve bioavailability for joint pain.
Joint discomfort, inflammation, arthritis, and reduced mobility. Affects all ages, worsens with age.
Also known as: Curcuma longa, Curcuminoids
Every published result for this pair, extracted and audited.
These charts group published studies by what they reported and how they were run — green marks studies that reported a benefit for this pairing. Tiers run from pooled analyses of many trials (strongest) to one-off observational reports.
Direction of reported outcomes for Turmeric / Curcumin in joint pain.
Study designs behind these findings.
Every measured outcome, one row per finding - numbers exactly as reported.
| Study | Design | n | Duration | Outcome measured | Reported result | Direction |
|---|---|---|---|---|---|---|
| PMID 34017975 2021 | Meta-analysis | 1621 | more than 12 weeks | Adverse events | reported qualitatively | Benefit |
| PMID 34017975 2021 | Meta-analysis | 1621 | more than 12 weeks | Joint pain, function, and stiffness | reported qualitatively | No benefit |
| PMID 34017975 2021 | Meta-analysis | 1621 | more than 12 weeks | Visual Analog Scale (VAS) and WOMAC scores (pain, function, stiffness) | reported qualitatively | Benefit |
| PMID 34017975 2021 | Meta-analysis | 1621 | more than 12 weeks | Visual Analog Scale (VAS) and WOMAC scores (pain, function, stiffness) | reported qualitatively | Benefit |
| PMID 32926799 2020 | Randomised trial | 70 | 12 weeks | effusion-synovitis volume on magnetic resonance imaging (MRI) | reported qualitatively (CI, -0.3 to 6.8 mL) | No benefit |
| PMID 32926799 2020 | Randomised trial | 70 | 12 weeks | knee pain on visual analogue scale (VAS) | -9.1 mm (95% CI, -17.8 to -0.4 mm [P = 0.039]) | Benefit |
| PMID 32926799 2020 | Randomised trial | 70 | 12 weeks | lateral femoral cartilage T2 relaxation time | reported qualitatively (CI, -1.1 to 0.3 ms) | No benefit |
| PMID 32926799 2020 | Randomised trial | 70 | 12 weeks | WOMAC knee pain | -47.2 mm (CI, -81.2 to -13.2 mm; P = 0.006) | Benefit |
Hand-selected PubMed studies, linked to the originals.
Ordered by strength of evidence, then result direction.
01Efficacy and Safety of Anti-nerve Growth Factor Monoclonal Antibodies in Managing Chronic Musculoskeletal Pain: A Systematic Review with Network Meta-analysisAbouelella A, et al. · Drugs · 2026PMID 41880116 ↗02Effect of collagen supplementation on knee osteoarthritis: an updated systematic review and meta-analysis of randomised controlled trialsSimental-Mendía M, et al. · Clinical and experimental rheumatology · 2025PMID 39212129 ↗03A meta-analysis and systematic review of the clinical efficacy and safety of platelet-rich plasma combined with hyaluronic acid (PRP + HA) versus PRP monotherapy for knee osteoarthritis (KOA)Du D, et al. · Journal of orthopaedic surgery and research · 2025PMID 39819683 ↗04Efficacy of dietary supplements for treating knee osteoarthritis: a systematic review and network meta-analysisBe the first to share what you noticed with Turmeric / Curcumin for joint pain. How we calculate this.